Topkan, Erkan <br/><br/>
Significance of overall concurrent chemoradiotherapy duration on survival outcomes of stage IIIB/C non-small-cell lung carcinoma patients: Analysis of 956 patients.  [electronic resource] 

 -  PloS one  2019 
 - e0218627 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0218627  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Chemoradiotherapy<br/>Female<br/>Humans<br/>Lymph Nodes--drug effects<br/>Male<br/>Middle Aged<br/>Neoplasm Staging<br/>Progression-Free Survival<br/>Treatment Outcome